Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Intervention1: N ACETYLCYSTEINE PREGABALIN: Patients with Type 2 diabetes mellitus and painful peripheral neuropathy advised to take Tab N Acetylcysteine 600mg twice daily with standard drug Tab Prega
Sponsors
Dr V Vijayalakshmi
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with type 2 diabetes having disease duration of more than 1 year Patients having HbA1C value of less than 10% Patients undergoing treatment with stable antidiabetic treatment more than 1 month and maintaining the same during the study Patients having diabetic neuropathy with an Neuropathy Disability Score more than 6 Visual Analogue Score of 4 Neuropathy Symptom Score more than 5Patients who are willing to participate in the study
Exclusion criteria
Exclusion criteria: Patients who are already on any other allopathic Homeopathic or ayurvedic medications for the treatment of neuropathy Patients with Peripheral neuropathy of other causes Patients with acute and chronic inflammatory conditions Patients with diabetic foot ulcers cerebrovascular disease discopathy Pregnancy and lactation History of drug allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in pain scoreTimepoint: Once in a month | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life assessment Fasting triglyceride levels Functional assessmentTimepoint: once in a month | — |
Countries
India
Contacts
Public ContactDr M Prakash
Govt Stanley medical college
Outcome results
None listed